Rebalance (Biotechnology) Overview
- Founded
- 2020
- Status
- Private
- Employees
- 5
- Latest Deal Type
- Series A
- Latest Deal Amount
- $6.7M
- Investors
- 1
Rebalance (Biotechnology) General Information
Description
Operator of a health and performance lifestyle company intended to optimize health and fitness. The company leverages biotechnology and enhanced delivery to create pure nutraceuticals and peptides, enabling customers to effectively maintain cortisol, testosterone and human growth hormone (hGH) levels in the body.
Contact Information
Website
www.rebalancehealth.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 1855 57th Court
- Suite 100
- Boulder, CO 80301
- United States
+1 (844) 000-0000
Rebalance (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 09-Nov-2021 | $6.7M | 00.00 | 000.00 | Completed | Generating Revenue |
Rebalance (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Rebalance (Biotechnology) Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Justin Hai | Chief Executive Officer, President & Board Member | ||
| Charles Kloeris | Secretary & Board Member | ||
| Scott Glenn | Treasurer & Board Member |
Rebalance (Biotechnology) Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Charles Kloeris | Rebalance (Biotechnology) | Secretary & Board Member | 000 0000 |
| James Breitmeyer Ph.D | Self | Board Member | 000 0000 |
| Justin Hai | Rebalance (Biotechnology) | Chief Executive Officer, President & Board Member | 000 0000 |
| Patrick Hopf | Self | Board Member | 000 0000 |
| Randy Hetrick | Self | Board Member | 000 0000 |
Rebalance (Biotechnology) Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialRebalance (Biotechnology) Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| The Ropart Asset Management Funds | PE/Buyout | Minority | 000 0000 | 000000 0 |